about
Interleukin-6 mediates angiotensinogen gene expression during liver regenerationPresenilin-1 regulates the expression of p62 to govern p62-dependent tau degradationNuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastomaProtein glycosylation in cancers and its potential therapeutic applications in neuroblastomaNeuregulin facilitates nerve regeneration by speeding Schwann cell migration via ErbB2/3-dependent FAK pathwayJARID1B Expression Plays a Critical Role in Chemoresistance and Stem Cell-Like Phenotype of Neuroblastoma CellsUnveiling MYCN regulatory networks in neuroblastoma via integrative analysis of heterogeneous genomics data.Ligand-dependent activation of EphA4 signaling regulates the proteolysis of amyloid precursor protein through a Lyn-mediated pathway.Liver-assist device with a microfluidics-based vascular bed in an animal model.GALNT2 suppresses malignant phenotypes through IGF-1 receptor and predicts favorable prognosis in neuroblastoma.Aryl hydrocarbon receptor downregulates MYCN expression and promotes cell differentiation of neuroblastoma.B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via β₁ integrin signaling in neuroblastoma.Changes in tumor growth and metastatic capacities of J82 human bladder cancer cells suppressed by down-regulation of calreticulin expression.Glycolytic inhibitor 2-deoxyglucose simultaneously targets cancer and endothelial cells to suppress neuroblastoma growth in miceMDA5 complements TLR3 in suppression of neuroblastomaTumor necrosis factor-alpha-elicited stimulation of gamma-secretase is mediated by c-Jun N-terminal kinase-dependent phosphorylation of presenilin and nicastrin.Retinoic acid-elicited RARα/RXRα signaling attenuates Aβ production by directly inhibiting γ-secretase-mediated cleavage of amyloid precursor proteinDiagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma.Clinicopathological feature and surgical outcome of choledochal cyst in different age groups: the implication of surgical timing.Co-expression analysis identifies long noncoding RNA SNHG1 as a novel predictor for event-free survival in neuroblastoma.A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.Management of congenital cystic adenomatoid malformation and bronchopulmonary sequestration in newborns.Role of glucose-regulated Protein 78 in embryonic development and neurological disorders.Calnexin is required for zebrafish posterior lateral line development.Insulin-like growth factor II mRNA-binding protein 3 expression predicts unfavorable prognosis in patients with neuroblastoma.Toll-like receptor 3 expression inhibits cell invasion and migration and predicts a favorable prognosis in neuroblastoma.Downregulation of c-Myc is involved in TLR3-mediated tumor death of neuroblastoma xenografts.β-1,4-Galactosyltransferase III suppresses extravillous trophoblast invasion through modifying β1-integrin glycosylation.Calreticulin Regulates VEGF-A in Neuroblastoma Cells.Calreticulin activates β1 integrin via fucosylation by fucosyltransferase 1 in J82 human bladder cancer cells.Proliferative effects of melatonin on Schwann cells: implication for nerve regeneration following peripheral nerve injury.B3GNT3 expression suppresses cell migration and invasion and predicts favorable outcomes in neuroblastoma.β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.Extracorporeal membrane oxygenation for neonatal congenital diaphragmatic hernia: The initial single-center experience in Taiwan.The prediction of drug metabolism using scaffold-mediated enhancement of the induced cytochrome P450 activities in fibroblasts by hepatic transcriptional regulators.Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.Caveolin-1 regulates γ-secretase-mediated AβPP processing by modulating spatial distribution of γ-secretase in membrane.Notch1 expression predicts an unfavorable prognosis and serves as a therapeutic target of patients with neuroblastoma.Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.In vitro analysis of a hepatic device with intrinsic microvascular-based channels.
P50
Q21132997-5252C1F6-20A5-4718-929F-312BC137D945Q24296704-0E3BC424-0739-49AF-9EBF-BE187F4D5A46Q27316571-E0E96EB6-9FB0-4F57-9430-99423C23DD2AQ28069952-E305B860-2255-471A-AB4D-4F27F851DE55Q28484778-95A1B4A4-061F-477F-8DF2-2EF459515965Q28547102-C3023869-3AD1-4E57-A094-1394A088A66AQ31095310-639DA552-94D0-40B6-8A16-F16E04023217Q31814817-EEF0AFA8-8A8C-4708-ACC0-08C9F53901CAQ33637230-C7612D3A-F89C-46EB-BA7C-E89395E46CDFQ35067906-88C93A62-C112-4418-9FC4-AE369EBAB7EBQ35106297-81EEDA0A-4216-44AC-A33F-9A36DEC8ACC2Q35168043-3F9D8177-6F3A-414D-8D68-A56E7CF71D4AQ35168250-D7B219AB-7535-4984-9862-2A9C97009CDBQ36175385-1A57FB31-93CC-4CA7-8BDA-15BE7F0B8684Q36413073-95E73F22-CFF3-47A7-A71F-F452394D3719Q36914318-10EEF53B-34D1-46F1-8AF4-40C3ADFD83E5Q37025855-90C6D033-445C-4272-A436-E1E3D93F5210Q37109868-25E6FD6A-CE44-4EA6-821D-5FAE83D28EA5Q37234513-C073E4EE-5668-43C3-BA6C-B74F1B26B15CQ37628972-69B49486-BB53-4F6E-98CE-AF31648BC413Q37706191-1AF1AFD6-A287-4AC8-8B27-6069E4AB5BEFQ37776942-4870AF8E-A28B-4F25-8DE3-093FC9C093F2Q37899563-57134E30-AE6F-4687-A0C5-E0E52B28DF85Q38313965-49FEFCF1-4337-4E24-B852-FF09B46A1735Q38331885-925B375D-02CD-4EA1-B37D-1E307A18BBB6Q38397485-B0083DAA-8D73-4FC1-A967-D9C161551DB7Q38770676-FE25A688-C66F-4FE8-B73F-D215665AC5ECQ38912222-2BA8DE30-4125-4337-B76D-1709518E8206Q38950119-8FBA0D9B-3D5C-41CC-BA12-0E966C0E2235Q39018762-31FDF1F2-BF1D-44FB-BF74-B7C92DAE651DQ39026882-11DC927C-D3C9-45D8-BF7F-D68381EAFC00Q39080654-80B705FE-0A61-4541-9344-0C1DDB45C2BCQ39187979-FCBB5B17-63F0-4361-87B2-12F281A94168Q39303009-A8963AD4-820E-4765-8341-6E7ED638BF36Q39357374-5241A80E-80C1-4447-B858-BEC46B8B8A45Q39459644-C8B01C3B-0CB9-490A-BC5A-40CAA8DEF4F6Q39654972-CBFA22A5-EE82-4058-95BB-32D3645D6566Q39663736-9557F67A-A4C6-4166-B2E3-FEFD1E1B3B4FQ39933548-7A8E1D0B-021B-4063-8EE9-A6101F100276Q39964524-1328BDEA-613B-4E64-AF29-1F6063038E48
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Wen-Ming Hsu
@ast
Wen-Ming Hsu
@en
Wen-Ming Hsu
@es
Wen-Ming Hsu
@nl
type
label
Wen-Ming Hsu
@ast
Wen-Ming Hsu
@en
Wen-Ming Hsu
@es
Wen-Ming Hsu
@nl
prefLabel
Wen-Ming Hsu
@ast
Wen-Ming Hsu
@en
Wen-Ming Hsu
@es
Wen-Ming Hsu
@nl
P106
P1153
55541817900
P31
P496
0000-0002-5145-9538